Cardiovascular Magnetic Resonance

The technique measures signals from hydrogen nuclei in cardiac and vascular tissues, then uses those signals to generate information beyond anatomical appearance. Variations in the measured signals support assessment of cardiac structure, motion, blood flow, tissue composition, and perfusion. This combination allows clinicians to evaluate both mechanical function and tissue characteristics within a single imaging approach.

Contrast-enhanced sequences add tissue-specific information that may not be apparent from structural or motion images alone. In particular, they can reveal myocardial scar or inflammation, helping distinguish different disease processes. This capability strengthens clinical interpretation when the central question concerns tissue injury or an active abnormality rather than anatomy alone.

Its value comes from combining quantitative measurements with tissue-sensitive observations. Cardiac motion, blood flow, perfusion, tissue composition, and the presence of scar or inflammation each provide a different perspective on disease. Considering these measurements together can help distinguish processes that may produce similar structural findings while supporting more precise assessment of cardiac status.

An assessment can combine images of cardiac structure and motion with measurements of blood flow, tissue composition, and perfusion. When clinically appropriate, contrast-enhanced sequences add information about myocardial scar or inflammation. The resulting examination provides complementary structural, functional, and tissue-level findings rather than relying on a single image type or measurement.

Clinicians use it to support diagnosis and monitoring across a broad range of conditions, including cardiomyopathies, ischemic heart disease, congenital abnormalities, valvular disorders, and vascular disease. Its role extends beyond initial detection because repeated quantitative and tissue-sensitive assessments can help evaluate disease status over time and inform ongoing clinical management.

Findings can guide treatment by clarifying disease characteristics that are not captured by anatomy alone. Measurements of function, perfusion, tissue composition, and myocardial scar or inflammation help characterize the underlying process. These results may also improve risk assessment by providing quantitative and tissue-sensitive evidence for evaluating disease severity and likely clinical significance.